...
机译:突变的Ikzf1 Kras〜(G12D)和Notch1在T谱系白血病发生中合作并调节对靶向药物的反应
Departments of Pediatrics, University of California, San Francisco, CA 94143;
rnDepartments of Medicine, University of California, San Francisco, CA 94143;
rnDepartments of Pediatrics, University of California, San Francisco, CA 94143;
rnDepartments of Pediatrics, University of California, San Francisco, CA 94143;
rnDepartment of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, Columbus, OH 43210;
rnDepartments of Pediatrics, University of California, San Francisco, CA 94143;
rnDepartments of Pediatrics, University of California, San Francisco, CA 94143;
rnDepartments of Laboratory Medicine, University of California, San Francisco, CA 94143;
rnDepartments of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143;
rnLaboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
rnDepartments of Pediatrics, University of California, San Francisco, CA 94143;
rnDepartments of Pediatrics, University of California, San Francisco, CA 94143;
K-ras; retroviral insertional mutagenesis; T cell leukemia; targeted therapeutics; Ikaros;
机译:通过靶向人和转基因(KRAS(G12D)和KRAS(G12D)/ TRP53(R172H))小鼠,通过靶向癌症干细胞抑制胰腺癌的α-芒果蛋白蛋白纳米粒子抑制胰腺癌
机译:对KRAS(G12D)的SOS1依赖于SOS1的独特依赖性诱导的白血病
机译:R201C突变气体的诱导与G12D突变Kras协同促进小鼠胰腺肿瘤发生。
机译:间充质细胞对生物材料的反应被其谱系中的成熟状态调节
机译:针对胰腺癌中的突变KRAS。
机译:突变体Ikzf1KrasG12D和Notch1在T谱系白血病发生中协同作用并调节对靶向药物的反应
机译:突变体Ikzf1,KrasG12D和Notch1在T谱系白血病发生中协同作用并调节对靶向药物的反应